Cancer Therapy
Findings in cancer therapy provide new insights
Published in Gene Therapy Weekly, March 16th, 2006
Study 1: According to recent research from the United States, melanoma differentiation-associated gene-7/interleukin-24 (mda-7/IL-24) has diverse antitumor properties.
"The holy grail of cancer therapy is to identify and exploit genetic elements and signal transduction pathways capable of selectively destroying tumor cells without eliciting harmful effects in normal cells or tissues," wrote P.B. Fisher and colleagues, Columbia University.
"To achieve this objective, subtraction hybridization was combined with a differentiation therapy model of cancer in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-03-16)
More Articles from Gene Therapy Weekly
- Alzheimer Disease
Acetylcholinesterase antisense inhibition may treat cognition deficit - Cancer Gene Therapy
Carcinoma-specific promoter controls efficient and selective adenoviral gene expression - Gene Silencing
Adenovirus-mediated small-interference RNA silences angiotensin AT(1a) receptors - Gene Transfer
Adenovirus-mediated gene transfer reveals pathways of HAS1 activation - RNA Interference
Protein-coding genes and short hairpin RNAs are simultaneously expressed in mammalian cells - Antisense Technology
Antisense oligodeoxynucleotides and diet eliminate resistant melanoma cells - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
